ArticleNature medicine2018

Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors.

Julia Boshuizen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.